15-epi-lipoxin A4-mediated induction of nitric oxide explains how aspirin inhibits acute inflammation - Test2 - elhamkhani - TriplyDB

15-epi-lipoxin A4-mediated induction of nitric oxide explains how aspirin inhibits acute inflammation

15-epi-lipoxin A4-mediated induction of nitric oxide explains how aspirin inhibits acute inflammation

http://www.wikidata.org/entity/Q24645794

about

Anti-inflammatory drugs and risk of Parkinson disease: A meta-analysis International Union of Basic and Clinical Pharmacology. LXXIII. Nomenclature for the formyl peptide receptor (FPR) family Advances in Our Understanding of Oxylipins Derived from Dietary PUFAs Does the use of acetylsalicylic acid have an influence on our vision?Platelets in inflammation and atherogenesis New insights into the anti-inflammatory actions of aspirin-induction of nitric oxide through the generation of epi-lipoxins New signaling routes for an old drug: lipoxin A4 might mediate heme oxygenase-1 induction by aspirin. Focus on "Novel lipid mediator aspirin-triggered lipoxin A4 induces heme oxygenase-1 in endothelial cells"Pharmacologic profile and therapeutic potential of NCX 4016, a nitric oxide-releasing aspirin, for cardiovascular disorders Roles of platelet and endothelial cell COX-1 in hypercholesterolemia-induced microvascular dysfunction Resolving inflammation: dual anti-inflammatory and pro-resolution lipid mediators Chronic inflammatory diseases are stimulated by current lifestyle: how diet, stress levels and medication prevent our body from recovering The lta4h locus modulates susceptibility to mycobacterial infection in zebrafish and humans Evidence for an anti-inflammatory loop centered on polymorphonuclear leukocyte formyl peptide receptor 2/lipoxin A4 receptor and operative in the inflamed microvasculature.Endogenous pro-resolving and anti-inflammatory lipid mediators: a new pharmacologic genus.Resolvin D2 is a potent regulator of leukocytes and controls microbial sepsis A randomized trial of aspirin at clinically relevant doses and nitric oxide formation in humans Specialized pro-resolving lipid mediators in the inflammatory response: An update Inflammation and its resolution as determinants of acute coronary syndromes.Short-term physical inactivity impairs vascular function.Dichotomy in duration and severity of acute inflammatory responses in humans arising from differentially expressed proresolution pathways.Pro-resolving actions and stereoselective biosynthesis of 18S E-series resolvins in human leukocytes and murine inflammation Nitric oxide is negatively correlated to pain during acute inflammation.Proresolving lipid mediators and mechanisms in the resolution of acute inflammation Endogenous lipid mediators in the resolution of airway inflammation Histone deacetylase 3 antagonizes aspirin-stimulated endothelial nitric oxide production by reversing aspirin-induced lysine acetylation of endothelial nitric oxide synthase.Novel lipid mediators promote resolution of acute inflammation: impact of aspirin and statins.Distinct signaling cascades elicited by different formyl peptide receptor 2 (FPR2) agonists Transgenic mice rich in endogenous omega-3 fatty acids are protected from colitis Mechanisms of non-opioid analgesics beyond cyclooxygenase enzyme inhibition.Consistent inhibition of cyclooxygenase drives macrophages towards the inflammatory phenotype A role for lipoxin A₄ as an anti-inflammatory mediator in the human endometrium Lovastatin decreases acute mucosal inflammation via 15-epi-lipoxin A4.Acetylsalicylic acid, but not clopidogrel, inhibits therapeutically induced cerebral arteriogenesis in the hypoperfused rat brain Association between aspirin therapy and the outcome in critically ill patients: a nested cohort study Lipoxin A4 promotes ABCA1 expression and cholesterol efflux through the LXRα signaling pathway in THP-1 macrophage-derived foam cells.Controlling inflammation: a fat chance?Short-Term, High-Dose Fish Oil Supplementation Increases the Production of Omega-3 Fatty Acid-Derived Mediators in Patients With Peripheral Artery Disease (the OMEGA-PAD I Trial)Lipoxin Signaling in Murine Lung Host Responses to Cryptococcus neoformans Infection.Native and aspirin-triggered lipoxins control innate immunity by inducing proteasomal degradation of TRAF6.Outcomes of severe sepsis and septic shock patients on chronic antiplatelet treatment: a historical cohort study.

P2860

Q22241651-228238DC-16CC-4159-B234-7109E1C65663 Q24652940-E029E560-57A6-483D-B3D6-C33E331558B6 Q27014988-B8B14508-59E2-48CA-805F-97FAF22B044D Q28066055-3C364D43-7DF1-4458-8909-C4408F04B9E2 Q28085020-1DD28D61-3518-4845-947C-653C613EA18B Q28180867-0CFF112B-F6BC-4C0F-A1A1-B44E9CD67501 Q28187259-337266F2-24FD-4E46-A436-FAAD122EC7CC Q28200449-FC0A2935-EE99-44C5-BDBE-AD684D6BB510 Q28222594-880BEE35-8094-4125-91E4-AF867EB9FD68 Q29615694-64591AE2-F6AC-4216-AB26-61B1446F5D27 Q30415505-14BFFDE8-6C9F-4035-946B-EC3DA9D3DE79 Q30495582-40EC3607-796B-4633-A963-FC1A1BECFA2D Q30504456-E9B808A3-2AF2-4006-9630-5B2727FED963 Q31134484-010F3095-BD8C-4023-B658-E8B2CF4E417C Q33513370-2D6FEA26-4CBB-43D0-996E-1A73066BC3E7 Q33582804-82039AEF-49E7-4BA1-A339-12419F4626FF Q33657562-4B58A7D0-5677-44F7-8DDC-657B1C31B908 Q33834800-A4387C32-F326-4F06-9165-6F965A42F1C4 Q33896015-5C002685-63E7-4CC3-834D-E8B5C7BDF462 Q33928544-4E987BAF-959A-4EED-832B-5DDCE2D82147 Q34157528-D9C54FF9-1693-4512-A8DD-EFEE23C5ED46 Q34173909-878DE169-F6DC-4698-970F-D475EF5BEB06 Q34411426-AD66128F-E66E-48BD-9D11-444F79D49FF6 Q34423359-587867B5-D339-44A2-B023-16B055A1DBE9 Q34514079-CCB5E596-2347-48BC-88F0-100C295A8E04 Q34522097-9AC66DEB-312D-4972-A043-639C9A3DFBC5 Q34645842-E7BE8F8B-2BEC-4EA9-A428-D0DDD8938417 Q34983954-CB513A53-DB6E-4965-9BB6-C89CB62A4579 Q35005089-BD1E4B2F-477D-4CC8-BE09-5560711D8897 Q35101603-BB25BDF8-372F-4D3A-8EB7-CDDFA7DB6CF3 Q35114951-816BDCAF-E4DF-49BC-8698-6E82BC23DEB2 Q35679301-4507CA74-3545-4F1E-AE90-2ABCF40592C2 Q35880859-E523E14F-4A90-4668-A445-520340F1244D Q35916354-A5CD9E96-7FEC-4EBC-87F2-6302B1E49C3A Q35919112-DEBE4806-5DAB-4072-B674-2202C6B033C9 Q36064465-81C6F0DD-777E-48C6-AD79-A97CB222611A Q36141602-B1B76443-907B-4476-9F93-A47DA4F34207 Q36549032-60445C8C-1C21-4F16-B8A8-FE4F2B08C78D Q36639986-852DA77A-33D0-47D9-B5C3-0D92A59CD111 Q36663432-75D84890-8A6E-495B-AC8D-004C4390E8CA

P2860

15-epi-lipoxin A4-mediated induction of nitric oxide explains how aspirin inhibits acute inflammation

http://www.wikidata.org/entity/Q24645794

description

2004 nî lūn-bûn

@nan

2004 թուականի Յուլիսին հրատարակուած գիտական յօդուած

@hyw

2004 թվականի հուլիսին հրատարակված գիտական հոդված

@hy

2004年の論文

@ja

2004年論文

@yue

2004年論文

@zh-hant

2004年論文

@zh-hk

2004年論文

@zh-mo

2004年論文

@zh-tw

2004年论文

@wuu

name

15-epi-lipoxin A4-mediated ind ...... in inhibits acute inflammation

@ast

15-epi-lipoxin A4-mediated ind ...... in inhibits acute inflammation

@en

15-epi-lipoxin A4-mediated ind ...... in inhibits acute inflammation

@nl

type

label

15-epi-lipoxin A4-mediated ind ...... in inhibits acute inflammation

@ast

15-epi-lipoxin A4-mediated ind ...... in inhibits acute inflammation

@en

15-epi-lipoxin A4-mediated ind ...... in inhibits acute inflammation

@nl

prefLabel

15-epi-lipoxin A4-mediated ind ...... in inhibits acute inflammation

@ast

15-epi-lipoxin A4-mediated ind ...... in inhibits acute inflammation

@en

15-epi-lipoxin A4-mediated ind ...... in inhibits acute inflammation

@nl

P1433

Q24645794-6BED6BCF-4B48-4A6C-BB9F-4A5955A1D938

P1476

Q24645794-9D2D8882-C6EC-4BC2-8EBB-4D40946AB3C4

P2093

Q24645794-25333CE1-6F0B-4F3F-8528-F3F0FF5B2009

Q24645794-72107678-C5FC-431F-AA93-BB86D55D6FF2

Q24645794-E4D1BA77-82E0-4E35-8C56-1AAF3027A105

Q24645794-E8B2AC15-DB89-4C68-86B3-65F4548415E8

P2860

Q24645794-00C52585-2100-463C-A9A0-2C07CC869EAD

Q24645794-054BAFCA-AF0D-4CEE-94C3-ED606C33977F

Q24645794-0C41DCC4-9D94-4C53-ABB1-FEC533FA1A37

Q24645794-158373D4-4A51-4AEC-AF2F-86DF9EC83BFD

Q24645794-18B99C2A-B114-49B7-A8E5-CC719B9F4041

Q24645794-1BB35356-5D87-4EDF-AF0B-B719B24FC2E5

Q24645794-1F706900-469B-4B35-B736-83DCCE39FBFC

Q24645794-23EB63CC-A460-4DDE-8E6F-EB994002B1C5

Q24645794-28E70003-DE81-4FB9-A306-73B19221AAFB

Q24645794-2BF019F6-9E84-456B-B85D-E07A49141003

P304

Q24645794-FFB158E6-68B3-46DE-B49D-E87A1DAAFC07

P31

Q24645794-57C0E233-8FF7-4F79-8461-B3563E69F107

P3181

Q24645794-4BDC4878-87D6-4EEA-AAEB-BDE510BD6BFE

P356

Q24645794-B47230CA-52F1-4DD9-BC57-07B537F829CB

P407

Q24645794-90107261-F995-44D2-A874-68C82CBCE255

P433

Q24645794-DB0A795C-A312-4BE9-AD09-E2B68A8DECFA

P478

Q24645794-23D1BF5B-BCE9-463E-8329-1994556B250B

P50

Q24645794-BEB195DE-12A1-487E-A2B2-E56C2C570B3F

P577

Q24645794-2F9DB1EA-BE42-4868-B77E-C123F0AE2F1D

P5875

Q24645794-0D603A43-3B2B-4B68-8B05-68E8959B2273

P698

Q24645794-9B992DEE-E3A4-4015-A076-A771CA23971D

P921

Q24645794-226DB996-C4EE-43C8-9BA7-1EA485702A03

Q24645794-59806114-CAAB-4CE8-A0A7-75651D737A22

P932

Q24645794-F7F30E5E-11A4-466F-85CA-FE89B2DFA70D

P3181

P356

P1433

Journal of Experimental Medicine

P1476

15-epi-lipoxin A4-mediated ind ...... in inhibits acute inflammation

@en

P2093

Dianne Cooper

http://www.w3.org/2001/XMLSchema#string

Mark J Paul-Clark

http://www.w3.org/2001/XMLSchema#string

Niloufar Moradi-Bidhendi

http://www.w3.org/2001/XMLSchema#string

Thong Van Cao

http://www.w3.org/2001/XMLSchema#string

P2860

Aspirin triggers previously undescribed bioactive eicosanoids by human endothelial cell-leukocyte interactions

Aspirin-triggered 15-epi-lipoxin A4 (LXA4) and LXA4 stable analogues are potent inhibitors of acute inflammation: evidence for anti-inflammatory receptors

Interaction of a selective cyclooxygenase-2 inhibitor with aspirin and NO-releasing aspirin in the human gastric mucosa

Aspirin, but not NO-releasing aspirin (NCX-4016), interacts with selective COX-2 inhibitors to aggravate gastric damage and inflammation

Cooperation between aspirin-triggered lipoxin and nitric oxide (NO) mediates antiadhesive properties of 2-(Acetyloxy)benzoic acid 3-(nitrooxymethyl)phenyl ester (NCX-4016) (NO-aspirin) on neutrophil-endothelial cell adherence

International Union of Pharmacology XXXVII. Nomenclature for leukotriene and lipoxin receptors

Unorthodox routes to prostanoid formation: new twists in cyclooxygenase-initiated pathways

Endogenous lipid- and peptide-derived anti-inflammatory pathways generated with glucocorticoid and aspirin treatment activate the lipoxin A4 receptor

Lipoxin A4 and aspirin-triggered 15-epi-lipoxin A4 modulate adhesion molecule expression on human leukocytes in whole blood and inhibit neutrophil-endothelial cell adhesion

Evidence that 5-lipoxygenase and acetylated cyclooxygenase 2-derived eicosanoids regulate leukocyte-endothelial adherence in response to aspirin

P304

69-78

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P3181

2095737

http://www.w3.org/2001/XMLSchema#string

P356

10.1084/JEM.20040566

http://www.w3.org/2001/XMLSchema#string

P407

P433

1

http://www.w3.org/2001/XMLSchema#string

P478

200

http://www.w3.org/2001/XMLSchema#string

P50

P577

2004-07-05T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

8469759

http://www.w3.org/2001/XMLSchema#string

P698

15238606

http://www.w3.org/2001/XMLSchema#string

P921

P932

2213311

http://www.w3.org/2001/XMLSchema#string